In 1973, biochemist Loren Pickart identified a small tripeptide in human plasma with an unusual property: it attracted liver cells and stimulated tissue repair in ways that couldn't be explained by nutrition or growth factors alone.
The compound was GHK-Cu — glycyl-L-histidyl-L-lysine bound to copper. It took another four decades for researchers to fully understand why it worked.
The Gene Regulation Discovery
The most significant finding in GHK-Cu research is not about collagen. It is about gene expression.
Studies using genome-wide analysis found that GHK-Cu modulates the activity of over 4,000 human genes — upregulating approximately 2,000 associated with tissue repair, cellular renewal, and anti-inflammatory signalling, while downregulating approximately 2,000 associated with cancer pathways, inflammation, and cellular degradation.
A subset of these — commonly referenced as "youth-associated genes" — are those active in young tissue that become progressively silenced with age. GHK-Cu appears to partially reactivate this expression profile.
This is not a cosmetic mechanism. It is a fundamental shift in how the cell receives and responds to repair signals.
What Declines With GHK-Cu
GHK-Cu is naturally present in plasma, saliva, and urine. Plasma concentrations peak in early adulthood and decline substantially — from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60.
The downstream effects of this decline include:
- Reduced fibroblast activity and collagen synthesis
- Slower wound closure and tissue remodelling
- Increased inflammatory baseline
- Diminished angiogenic signalling
These are not independent processes. They are coordinated outputs of a single regulatory system — one that GHK-Cu appears to anchor.
Mechanisms Under Research
Collagen and structural matrix: GHK-Cu stimulates synthesis of collagen types I and III and promotes fibroblast proliferation. Research in wound healing models consistently shows accelerated closure and improved tensile strength of repaired tissue.
Anti-inflammatory regulation: GHK-Cu modulates TNF-α and other pro-inflammatory cytokines. In chronic inflammatory models, it reduces the oxidative stress environment that impairs repair.
Angiogenesis: Vascular support is a prerequisite for tissue repair. GHK-Cu promotes new blood vessel formation, improving oxygen and nutrient delivery to sites of remodelling.
Nervous system: Emerging research suggests neuroprotective properties — including nerve growth factor stimulation and antioxidant enzyme upregulation in neural tissue.
The Glow Protocol
In compound stacking research, GHK-Cu is frequently combined with BPC-157 (gut and tendon healing) and TB-500 (cell migration and circulation support) in what researchers refer to as a comprehensive regenerative protocol.
The rationale: GHK-Cu provides the gene-level signal for renewal. BPC-157 supports structural repair at mucosal and connective tissue sites. TB-500 drives the cellular migration and vascular support needed to deliver resources to repair sites.
Together, they address structure, flow, and the foundational renewal signal — three distinct layers of the same biological process.
Why It Keeps Appearing in Research
GHK-Cu is not a novel discovery. It is a rediscovery of something that was always there — a native regulatory signal that the body produces abundantly in youth and increasingly cannot maintain with age.
Research interest has accelerated because its mechanism is unusually broad, unusually well-documented, and unusually consistent across tissue types. That combination is rare.
*For laboratory and educational research use only. Not approved for human or veterinary use.*